Erastin, a classic SLC7A11 inhibitor, was observed to induce intense cytotoxicity on colorectal cancer stem cells in vitro and in vivo and mitigated the chemoresistance of colorectal cancer stem cells.108. This evidence concerns the gene SLC7A11 and colorectal cancer.